The National Institutes of Health “Methods and Measurement in Sexual & Gender Minority Health Research: Identifying Research Opportunities”, 9538-9539 [2019-04790]

Download as PDF 9538 Federal Register / Vol. 84, No. 51 / Friday, March 15, 2019 / Notices Patricia M. Busche, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2019–04856 Filed 3–14–19; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P Center for Scientific Review; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting amozie on DSK9F9SC42PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; RFA–AA–19–001 Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA). Date: April 29, 2019. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Main Conference Hall, 6700A Rockledge Drive, Bethesda, MD 20817. Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700B Rockledge Drive, Room 2116, Bethesda, MD 20852, 301–443– 0800, bbuzas@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) Dated: March 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–04852 Filed 3–14–19; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 16:53 Mar 14, 2019 Jkt 247001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Autism and Other Neurodevelopmental Disorders. Date: March 26, 2019. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Samuel C. Edwards, Ph.D., Chief, BDCN IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, Bethesda, MD 20892, (301) 435–1246, edwardss@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Toxicology and Digestive, Kidney and Urological Systems AREA Review. Date: April 3, 2019. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182 MSC 7818, Bethesda, MD 20892, 301–827–5467, ganesan.ramesh@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Dated: March 12, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–04850 Filed 3–14–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The National Institutes of Health ‘‘Methods and Measurement in Sexual & Gender Minority Health Research: Identifying Research Opportunities’’ ACTION: Request for comments. Sexual and gender minority (SGM) is an umbrella phrase that encompasses lesbian, gay, bisexual, and transgender populations as well as those whose sexual orientation, gender identity and expressions, or reproductive development varies from traditional, societal, cultural, or physiological norms. This includes Disorders or Differences in Sex Development (DSD), sometimes known as intersex. The Sexual & Gender Minority Research Office (SGMRO) at the National Institutes of Health (NIH) has developed the document ‘‘Methods and Measurement in Sexual & Gender Minority Health Research: Identifying Research Opportunities’’ pertaining specifically and exclusively to methods and measurement research in SGM health research. Experts in the field identified research opportunities related to methods and measurement in SGM health research during a workshop held in the Spring of 2018. The document reflects the content of the discussion among participants at the Methods and Measurement in SGM Health Research Workshop and does not represent an official position of NIH or any other government agency. We would like to obtain comment on the specifics of this document to consider for the purposes of informing and enhancing its content. DATES: To ensure consideration of your comments, responses must be received by April 15, 2019. ADDRESSES: Responses to this notice must be submitted electronically by email to sgmhealthresearch@od.nih.gov. Please use the subject ‘‘Comments: Measurement.’’ SUMMARY: Dr. Karen Parker, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, Building 1, Room 257, 1 Center Drive, FOR FURTHER INFORMATION CONTACT: E:\FR\FM\15MRN1.SGM 15MRN1 Federal Register / Vol. 84, No. 51 / Friday, March 15, 2019 / Notices Bethesda, MD 20892, Telephone: 301– 451–2055, Email: karen.parker@nih.gov. SUPPLEMENTARY INFORMATION: amozie on DSK9F9SC42PROD with NOTICES Background In 2015, the National Institutes of Health (NIH) established the Sexual & Gender Minority Research Office (SGMRO) in the Division of Program Coordination, Planning, and Strategic Initiatives in the Office of the Director. The role of the SGMRO is to: Coordinate sexual and gender minority (SGM) health research activities across NIH; represent NIH at conferences and events on trans-NIH activities focused on SGM research; coordinate and convene conferences and workshops to inform priority setting and research activities; collaborate with NIH Institutes and Centers on the development of SGM health research reports; manage information dissemination related to SGM research; and work with NIH Institutes and Centers to leverage resources and develop initiatives to support SGM health research. The 21st Century Cures Act, signed into law on December 13, 2016, included SGM-specific provisions, by amending the Public Health Service Act, SEC. 404N. [283] POPULATION FOCUSED RESEARCH. Those provisions are summarized as follows: ‘‘The Director of the National Institutes of Health shall, as appropriate, encourage efforts to improve research related to the health of sexual and gender minority populations, including by: facilitating increased participation of sexual and gender minority populations in clinical research supported by the National Institutes of Health, and reporting on such participation, as applicable; facilitating the development of valid and reliable methods for research relevant to sexual and gender minority populations; and addressing methodological challenges.’’ As a result of the growing need to develop better measures and methods to accurately capture and understand the health of SGM populations, the SGMRO hosted a workshop to identify research opportunities in methods and measurement in SGM-related health research. The planning committee included both NIH staff and extramural researchers who designed the workshop agenda and developed a schema to guide the discussions. The workshop focused on three areas: Measurement of SGM status; measurement of related constructs; and sampling. Extramural researchers were invited who represented various research areas, stages of career, populations of interest, and disciplines. VerDate Sep<11>2014 16:53 Mar 14, 2019 Jkt 247001 Community members, NIH staff, and other federal staff were also included. Discussions focused around varying concepts to consider under each of the domains identified by the planning committee; overarching themes of intersectionality, lifespan, culture, and historical context and cohort effects were considered throughout the discussions. The concepts for consideration are highlighted below: I. Measurement of SGM Status Æ Sexual Orientation (identity, behavior, attraction) Æ Gender Identity (cisgender, transgender, gender nonconforming, non-binary) Æ Disorders or Differences of Sex Development/Intersex (medical condition at birth vs. self-identified) Æ Fluidity (identity across contexts, time, and developmental stage) Æ Assessment Modality (survey, report, collection from a provider, on the phone, internet, paper) Æ Clinical Settings II. Measurement of Related Constructs Æ Stigma (structural, interpersonal, individual or internalized) Æ Coming Out/Disclosure Process Æ Family Relationships Æ Cultural Competence/Humility in the Healthcare and Research Settings (providers, facilities, etc.) III. Sampling Æ Probability vs. Non-Probability Sampling Æ Sampling Across Demographics/Subpopulations Æ Small Sample Sizes Information Requested This notice invites public comment on the proposed research needs and opportunities developed at the Methods and Measurement in Sexual and Gender Minority Health Research Workshop. To inform the final document, comment is requested on the following questions: (1) What are the most important and relevant methods and measurementrelated research questions to members of the SGM community? (2) What are the key methods and measurement-related research questions missing from the research opportunities that should be included? Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. April 15, 2019. General Information All of the following fields in the response are optional and voluntary. PO 00000 Frm 00064 Fmt 4703 Sfmt 9990 9539 Any personal identifiers will be removed when responses are compiled. Proprietary, classified, confidential, or sensitive information should not be included in your response. This notice is for planning purposes only and is not a solicitation for applications or an obligation on the part of the United States (U.S.) government to provide support for any ideas identified in response to it. Please note that the U.S. government will not pay for the preparation of any comment submitted or for its use of that comment. Please indicate if you are one of the following: Grantee or other PI, administrator, student, institutional leader or institutional administrator, NIH employee, or other. If you are an investigator, please indicate your career level and main area of research interest, including whether the focus is clinical or basic. If you are a member of a particular advocacy or professional organization, please indicate the name and primary focus of the organization (e.g., research support, patient care, etc.) and whether you are responding on behalf of your organization (if yes, please indicate your position within the organization). Please provide your name and email address. Privacy Act Notification Statement: We are requesting your comments for Methods and Measurement in Sexual & Gender Minority Health Research: Developing a Research Agenda and Identifying Research Opportunities (https://dpcpsi.nih.gov/sites/default/ files/MethodsMeasures_Paper_508_ FV.pdf). The information you provide may be disclosed to NIH senior staff and those serving on the SGM Research Coordinating Committee and to contractors working on our behalf. Submission of this information is voluntary. However, the information you provide will help to categorize responses by scientific area of expertise, organizational entity or professional affiliation. Collection of this information is authorized under 42 U.S.C. 203, 24 1, 2891–1 and 44 U.S.C. 310 I and Section 30l and 493 of the Public Health Service Act regarding the establishment of the National Institutes of Health, its general authority to conduct and fund research and to provide training assistance, and its general authority to maintain records in connection with these and its other functions. Dated: March 8, 2019. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2019–04790 Filed 3–14–19; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 84, Number 51 (Friday, March 15, 2019)]
[Notices]
[Pages 9538-9539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04790]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Institutes of Health ``Methods and Measurement in 
Sexual & Gender Minority Health Research: Identifying Research 
Opportunities''

ACTION: Request for comments.

-----------------------------------------------------------------------

SUMMARY: Sexual and gender minority (SGM) is an umbrella phrase that 
encompasses lesbian, gay, bisexual, and transgender populations as well 
as those whose sexual orientation, gender identity and expressions, or 
reproductive development varies from traditional, societal, cultural, 
or physiological norms. This includes Disorders or Differences in Sex 
Development (DSD), sometimes known as intersex.
    The Sexual & Gender Minority Research Office (SGMRO) at the 
National Institutes of Health (NIH) has developed the document 
``Methods and Measurement in Sexual & Gender Minority Health Research: 
Identifying Research Opportunities'' pertaining specifically and 
exclusively to methods and measurement research in SGM health research. 
Experts in the field identified research opportunities related to 
methods and measurement in SGM health research during a workshop held 
in the Spring of 2018. The document reflects the content of the 
discussion among participants at the Methods and Measurement in SGM 
Health Research Workshop and does not represent an official position of 
NIH or any other government agency. We would like to obtain comment on 
the specifics of this document to consider for the purposes of 
informing and enhancing its content.

DATES: To ensure consideration of your comments, responses must be 
received by April 15, 2019.

ADDRESSES: Responses to this notice must be submitted electronically by 
email to sgmhealthresearch@od.nih.gov. Please use the subject 
``Comments: Measurement.''

FOR FURTHER INFORMATION CONTACT: Dr. Karen Parker, Division of Program 
Coordination, Planning, and Strategic Initiatives, Office of the 
Director, NIH, Building 1, Room 257, 1 Center Drive,

[[Page 9539]]

Bethesda, MD 20892, Telephone: 301-451-2055, Email: 
karen.parker@nih.gov.

SUPPLEMENTARY INFORMATION: 

Background

    In 2015, the National Institutes of Health (NIH) established the 
Sexual & Gender Minority Research Office (SGMRO) in the Division of 
Program Coordination, Planning, and Strategic Initiatives in the Office 
of the Director. The role of the SGMRO is to: Coordinate sexual and 
gender minority (SGM) health research activities across NIH; represent 
NIH at conferences and events on trans-NIH activities focused on SGM 
research; coordinate and convene conferences and workshops to inform 
priority setting and research activities; collaborate with NIH 
Institutes and Centers on the development of SGM health research 
reports; manage information dissemination related to SGM research; and 
work with NIH Institutes and Centers to leverage resources and develop 
initiatives to support SGM health research.
    The 21st Century Cures Act, signed into law on December 13, 2016, 
included SGM-specific provisions, by amending the Public Health Service 
Act, SEC. 404N. [283] POPULATION FOCUSED RESEARCH. Those provisions are 
summarized as follows:
    ``The Director of the National Institutes of Health shall, as 
appropriate, encourage efforts to improve research related to the 
health of sexual and gender minority populations, including by: 
facilitating increased participation of sexual and gender minority 
populations in clinical research supported by the National Institutes 
of Health, and reporting on such participation, as applicable; 
facilitating the development of valid and reliable methods for research 
relevant to sexual and gender minority populations; and addressing 
methodological challenges.''
    As a result of the growing need to develop better measures and 
methods to accurately capture and understand the health of SGM 
populations, the SGMRO hosted a workshop to identify research 
opportunities in methods and measurement in SGM-related health 
research. The planning committee included both NIH staff and extramural 
researchers who designed the workshop agenda and developed a schema to 
guide the discussions.
    The workshop focused on three areas: Measurement of SGM status; 
measurement of related constructs; and sampling. Extramural researchers 
were invited who represented various research areas, stages of career, 
populations of interest, and disciplines.
    Community members, NIH staff, and other federal staff were also 
included. Discussions focused around varying concepts to consider under 
each of the domains identified by the planning committee; overarching 
themes of intersectionality, lifespan, culture, and historical context 
and cohort effects were considered throughout the discussions. The 
concepts for consideration are highlighted below:

I. Measurement of SGM Status

[cir] Sexual Orientation (identity, behavior, attraction)
[cir] Gender Identity (cisgender, transgender, gender nonconforming, 
non-binary)
[cir] Disorders or Differences of Sex Development/Intersex (medical 
condition at birth vs. self-identified)
[cir] Fluidity (identity across contexts, time, and developmental 
stage)
[cir] Assessment Modality (survey, report, collection from a provider, 
on the phone, internet, paper)
[cir] Clinical Settings

II. Measurement of Related Constructs

[cir] Stigma (structural, interpersonal, individual or internalized)
[cir] Coming Out/Disclosure Process
[cir] Family Relationships
[cir] Cultural Competence/Humility in the Healthcare and Research 
Settings (providers, facilities, etc.)

III. Sampling

[cir] Probability vs. Non-Probability Sampling
[cir] Sampling Across Demographics/Sub-populations
[cir] Small Sample Sizes

Information Requested

    This notice invites public comment on the proposed research needs 
and opportunities developed at the Methods and Measurement in Sexual 
and Gender Minority Health Research Workshop. To inform the final 
document, comment is requested on the following questions:
    (1) What are the most important and relevant methods and 
measurement-related research questions to members of the SGM community?
    (2) What are the key methods and measurement-related research 
questions missing from the research opportunities that should be 
included?
    Comments regarding this information collection are best assured of 
having their full effect if received within 30 days of the date of this 
publication. April 15, 2019.

General Information

    All of the following fields in the response are optional and 
voluntary. Any personal identifiers will be removed when responses are 
compiled. Proprietary, classified, confidential, or sensitive 
information should not be included in your response. This notice is for 
planning purposes only and is not a solicitation for applications or an 
obligation on the part of the United States (U.S.) government to 
provide support for any ideas identified in response to it. Please note 
that the U.S. government will not pay for the preparation of any 
comment submitted or for its use of that comment.
    Please indicate if you are one of the following: Grantee or other 
PI, administrator, student, institutional leader or institutional 
administrator, NIH employee, or other. If you are an investigator, 
please indicate your career level and main area of research interest, 
including whether the focus is clinical or basic. If you are a member 
of a particular advocacy or professional organization, please indicate 
the name and primary focus of the organization (e.g., research support, 
patient care, etc.) and whether you are responding on behalf of your 
organization (if yes, please indicate your position within the 
organization). Please provide your name and email address.
    Privacy Act Notification Statement: We are requesting your comments 
for Methods and Measurement in Sexual & Gender Minority Health 
Research: Developing a Research Agenda and Identifying Research 
Opportunities (https://dpcpsi.nih.gov/sites/default/files/MethodsMeasures_Paper_508_FV.pdf). The information you provide may be 
disclosed to NIH senior staff and those serving on the SGM Research 
Coordinating Committee and to contractors working on our behalf. 
Submission of this information is voluntary. However, the information 
you provide will help to categorize responses by scientific area of 
expertise, organizational entity or professional affiliation.
    Collection of this information is authorized under 42 U.S.C. 203, 
24 1, 2891-1 and 44 U.S.C. 310 I and Section 30l and 493 of the Public 
Health Service Act regarding the establishment of the National 
Institutes of Health, its general authority to conduct and fund 
research and to provide training assistance, and its general authority 
to maintain records in connection with these and its other functions.

    Dated: March 8, 2019.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2019-04790 Filed 3-14-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.